In locally advanced gastric cancer, the prognostic values of HGF/MET expression in tumor tissue has also been investigated and found to be a poor prognostic factor in patients who were treated by surgical resection or chemotherapy [35–41]. The gene discussed is HGF; the disease is gastric cancer.